Obstructive Sleep Apnea and Insomnia: Clinical Significance and Management

Recognition and Diagnosis

The American Academy of Sleep Medicine recognizes that comorbid insomnia is a frequent problem in patients with OSA, and a comprehensive sleep evaluation must address both OSA and other comorbid sleep complaints 1
A comprehensive sleep history in suspected OSA patients should specifically evaluate for sleep fragmentation and sleep maintenance insomnia as core symptoms, alongside snoring, witnessed apneas, gasping/choking episodes, excessive sleepiness, nocturia, morning headaches, and decreased concentration 2
The insomnia in OSA patients manifests as difficulty maintaining sleep due to repetitive arousals from apneic events 2
Nocturnal awakenings with gasping or choking sensations are common in OSA patients 1
Sleep fragmentation from respiratory effort-related arousals and cortical arousals associated with hypopneas contributes to insomnia in OSA patients 1

Repetitive hypoxemia during apneic episodes triggers oxidative stress and autonomic dysregulation, contributing to insomnia symptoms 3
Autonomic nervous system dysregulation with surges in sympathetic activity and blood pressure fluctuations during arousal from apnea contributes to insomnia 3
Intrathoracic pressure swings alter cardiac loading conditions and fragment sleep architecture, leading to insomnia 3
Systemic inflammation and endothelial dysfunction promote both cardiovascular disease and sleep disruption, including insomnia 3

Patients with higher BMI and comorbid conditions, such as hypertension and diabetes, have substantially elevated OSA prevalence, reaching 56-70% in obese individuals 4
OSA prevalence in hypertensive patients approaches 60%, particularly in those with resistant hypertension 4
Chronic intermittent hypoxia from OSA worsens insulin resistance, creating a vicious cycle with obesity and diabetes 4
The metabolic syndrome components cluster with OSA, requiring assessment of fasting glucose, HbA1c, and lipid panels 4
Polysomnography remains the reference standard for diagnosing OSA, with diagnostic criteria requiring either obstructive RDI ≥5 events/hour with typical symptoms or obstructive RDI ≥15 events/hour even without symptoms 1
CPAP therapy addresses both the OSA and associated insomnia symptoms by eliminating respiratory events and sleep fragmentation 5
CPAP use of ≥4 hours per night reduces cardiovascular events from 11.02 to 7.90 events per 100 person-years 5
Weight loss improves OSA severity, hypertension, and insulin resistance in obese patients with COMISA 4